¼¼°èÀÇ ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷ ½ÃÀå : ¼¼Æ÷ À¯Çüº°, ÄÄÇÇÅÙÆ® À¯Çüº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2024-2032³â)
Electrocompetent Cells Market, By Cell Type, By Competency Type, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
»óǰÄÚµå : 1555702
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2024³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 345 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,503,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,443,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 7,829,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

º¸°í¼­ ÇÏÀ̶óÀÌÆ®

ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷ ½ÃÀå ±Ô¸ð´Â 2023³â¿¡ 21¾ï 7,798¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³âºÎÅÍ 2032³â¿¡ °ÉÃÄ º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 10.6%·Î È®´ëµÉ Àü¸ÁÀÔ´Ï´Ù.

ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷ ½ÃÀå : ½ÃÀå ¿ªÇÐ

À¯Àü¼º ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡Çϸé ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷ ¼ö¿ä°¡ Áõ°¡

À¯Àü¼º ÁúȯÀÇ À¯º´·ü Áõ°¡´Â À¯ÀüÀÚ Å¬·Î´× ¹× À¯Àü °øÇп¡ ÇʼöÀûÀÎ ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷¿¡ ´ëÇÑ ¼ö¿ä¸¦ Å©°Ô Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ¹Ì±¹ ±¹¸³À§»ý¿¬±¸¼Ò(NIH)´Â Áö³­ 5³â°£ À¯ÀüÀÚ ÁúȯÀ» Æ÷ÇÔÇÑ ¿¬±¸ ÇÁ·ÎÁ§Æ®°¡ 30% Áõ°¡Çß´Ù°í º¸°íÇß½À´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)´Â À¯Àü¼º ÁúȯÀÌ Ãâ»ý¾ÆÀÇ ¾à 200¸í¿¡ 1¸íÀÇ ºñÀ²·Î ¹ßº´Çϰí ÀÖÀ½À» °­Á¶Çϸç, °í±Þ ¿¬±¸ µµ±¸ÀÇ Çʿ伺À» Ã˱¸Çϰí ÀÖ½À´Ï´Ù. Bio-Rad Laboratories ¹× Thermo Fisher Scientific°ú °°Àº ±â¾÷Àº À¯ÀüÀÚ ¿¬±¸ ¹× Ä¡·á¿¡ ´ëÇÑ °ü½É Áõ°¡¿¡ ´ëÀÀÇÏ°í °í±Þ ÀüÀÚ ¿ª·® ¼¿À» Æ÷ÇÔÇÑ Æ÷Æ®Æú¸®¿À¸¦ È®´ëÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼ö¿äÀÇ ±ÞÁõÀº À¯ÀüÀÚ ¿¬±¸¿Í ¸ÂÃãÇü ÀÇ·áÀÇ Áøº¸¸¦ °¡¼ÓÈ­Çϴµ¥ À־ ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¿ÀÇ Áß¿äÇÑ ¿ªÇÒÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷ ½ÃÀå : ÁÖ¿ä ÀλçÀÌÆ®·Â

¿ì¸®ÀÇ ¸®¼­Ä¡ ¾Ö³Î¸®½ºÆ®ÀÇ ºÐ¼®¿¡ µû¸£¸é ½ÃÀåÀº ¿¹Ãø ±â°£ µ¿¾È¿¡ ¾à 10.6%ÀÇ º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)·Î ¸Å³â ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼Æ÷ À¯Çü ¼¼ºÐÈ­¿¡ ±Ù°ÅÇÏ¿©, ¹ÚÅ׸®¾Æ ¼¼Æ÷´Â 2023³â¿¡ ÃÖ´ë ½ÃÀå Á¡À¯À²À» º¸¿©ÁÙ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

2023³â¿¡´Â À¯´ÉÇÑ À¯ÇüÀÇ ¼¼±×¸ÕÅ×À̼ÇÀ» ±â¹ÝÀ¸·Î ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷ÀÌ ÁÖ¿ä À¯ÇüÀ̾ú½À´Ï´Ù.

¿ëµµº°·Î´Â 2023³â¿¡´Â ´Ü¹éÁú ¹ßÇöÀÌ ÁÖ¿ä À¯ÇüÀ̾ú½À´Ï´Ù.

Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2023³â ¼öÀÍÀ¸·Î À̲ø¾ú½À´Ï´Ù.

ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷ ½ÃÀå : ¼¼ºÐÈ­ ºÐ¼® :

¼¼°è ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷ ½ÃÀåÀº ¼¿ À¯Çü, ÄÄÇÇÅÏÆ® À¯Çü, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚ, Áö¿ª¿¡ µû¶ó ¼¼ºÐÈ­µË´Ï´Ù.

½ÃÀåÀº ¼¼Æ÷ À¯Çü¿¡ µû¶ó ³× °¡Áö ¹üÁÖ·Î ³ª´¹´Ï´Ù. ¼¼±Õ ¼¼Æ÷, È¿¸ð ¼¼Æ÷, ½Ä¹° ¼¼Æ÷, Æ÷À¯·ù ¼¼Æ÷ÀÔ´Ï´Ù. ¹ÚÅ׸®¾Æ ¼¼Æ÷´Â À¯ÀüÀÚ ¿¬±¸¿¡ ³Î¸® »ç¿ëµÇ±â ¶§¹®¿¡ ¼ö¿ä°¡ ³ô°í, È¿¸ð ¼¼Æ÷´Â ±â´É ¿¬±¸¿¡ ÇʼöÀûÀÔ´Ï´Ù. Æ÷À¯·ù ¼¼Æ÷´Â °í±Þ ¿ëµµ¿¡ Áß¿äÇÏ¸ç ½Ä¹° ¼¼Æ÷´Â ´ú ÀαⰡ ÀÖ½À´Ï´Ù.

½ÃÀåÀº À¯´ÉÇÑ À¯Çü¿¡ µû¶ó µÎ °¡Áö ¹üÁÖ·Î ³ª´¹´Ï´Ù. ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷Àº ÇüÁúÀüȯ °úÁ¤¿¡¼­ È¿À²¼º¿¡ ¿ì¼±ÀûÀ¸·Î »ç¿ëµÇ¸ç, È­ÇÐÀû ÄÄÇÇÅÏÆ® ¼¼Æ÷´Â ƯÁ¤ ¿ëµµ¿¡ »ç¿ëµË´Ï´Ù. ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷Àº ¹ü¿ë¼º°ú À¯ÀüÀÚ Á¶ÀÛ¿¡ À־ÀÇ È¿´É¿¡ ÀÇÇØ º¸´Ù ³ôÀº ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù.

ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷ ½ÃÀå : Áö¸®Àû ÀλçÀÌÆ®

ºÏ¹Ì´Â °ßÁ¶ÇÑ »ý¸í°øÇÐ ºÎ¹®°ú ´ë±Ô¸ð ¿¬±¸ ÅõÀÚ¸¦ ÅëÇØ ¼±µµÇϰí ÀÖ½À´Ï´Ù. ¹Ì±¹Àº ±¹¸³À§»ý¿¬±¸¼Ò(National Institutes of Health) µîÀÇ ±â°üÀÌ À¯Àü°øÇÐÀÇ ±¤¹üÀ§ÇÑ Á¶»ç¸¦ Áö¿øÇϰí ÀÖÀ¸¸ç, ÀÌ Áö¿ªÀÇ ¿ìÀ§¼º¿¡ °øÇåÇϰí ÀÖ½À´Ï´Ù. °­·ÂÇÑ Á¦¾à»ê¾÷°ú »ý¸í°øÇлê¾÷ÀÌ °ßÀÎÇÏ´Â À¯·´ÀÌ ÀÌ¿¡ À̾îÁý´Ï´Ù. À¯·´¿¬ÇÕ(EU)ÀÇ 'È£¶óÀÌÁð, À¯·´' ÇÁ·Î±×·¥Àº À¯ÀüÀÚ¿¬±¸¿Í ¼¼Æ÷±â¼ú¿¡ °üÇÑ ¼ö¸¹Àº ÇÁ·ÎÁ§Æ®¿¡ ÀÚ±ÝÀ» Á¦°øÇØ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾ç, ƯÈ÷ Áß±¹°ú Àεµ´Â »ý¸í °øÇп¡¼­ ¿¬±¸ Ȱµ¿°ú ÅõÀÚ°¡ Áõ°¡ÇÔ¿¡ µû¶ó ±Þ¼ÓÈ÷ »ó½ÂÇϰí ÀÖ½À´Ï´Ù. Áß±¹ÀÇ ±¹°¡Á¤Ã¥Àº À¯ÀüÀÚ¿¬±¸¿Í »ý¸í°øÇÐÀÇ ÁøÀüÀ» ÁöÁöÇϰí ÀÖÀ¸¸ç, ÇöÁö ´ëÇаú »ý¸í°øÇбâ¾÷°£¿¡ ¿©·¯ °øµ¿¿¬±¸°¡ ÁøÇàµÇ¾î ½ÃÀåÀÇ Á¸Àç°¨À» ³ôÀ̰í ÀÖ½À´Ï´Ù. ¶óƾ¾Æ¸Þ¸®Ä«¿¡¼­´Â ºê¶óÁúÀÌ ¿¬±¸½Ã¼³ Áõ°¡¿Í ±¹Á¦ »ý¸í °øÇÐ ±â¾÷°úÀÇ Á¦È޷ΠȰ¾àÇϰí ÀÖ½À´Ï´Ù. °¢ Áö¿ªÀº Áö¿ªÀÇ ¿¬±¸ ÀÌ´Ï¼ÅÆ¼ºê¿Í Áö¿ø Á¤Ã¥¿¡ ÈûÀÔ¾î ´Ù¾çÇÑ °­Á¡À¸·Î ½ÃÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷ ½ÃÀå : °æÀï ±¸µµ:

À¯·Â ±â¾÷ÀÎ Invitrogen CorporationÀº À¯Àü ¿¬±¸ ¾ÖÇø®ÄÉÀ̼ÇÀ» ÃßÁøÇϱâ À§ÇØ Ä¶¸®Æ÷´Ï¾Æ ´ëÇаúÀÇ Á¦ÈÞ µî Àü·«Àû Á¦ÈÞ¸¦ ÅëÇØ ±× ÁöÀ§¸¦ °­È­Çϰí ÀÖ½À´Ï´Ù. ¶Ç ´Ù¸¥ ÁÖ¿ä ±â¾÷ÀÎ Bio-Rad Laboratories´Â ÃÖ±Ù ¼±µµÀû ÀÎ »ý¸í °øÇÐ ±â¾÷ÀÇ ¼¼Æ÷ »ý¹°ÇÐ ºÎ¹®À» ÀμöÇÏ¿© Á¦Ç° Æ÷Æ®Æú¸®¿À¸¦ È®ÃæÇϰí ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷¿¡¼­ Á¦Ç° Á¦°øÀ» °­È­Çϰí ÀÖ½À´Ï´Ù. ¾ÖÁú·±Æ® ±â¼úÀº À¯Àü°øÇÐÀ» Çõ½ÅÇϱâ À§ÇÑ ¿¬±¸ ÆÄÆ®³Ê½ÊÀ» Àû±ØÀûÀ¸·Î ¸Î°í ÀÖÀ¸¸ç, ±× ¾È¿¡´Â »õ·Î¿î ¾ÖÇø®ÄÉÀÌ¼Ç °³¹ßÀ» À§ÇÑ Á¦¾àȸ»ç ¿©·¯ ȸ»ç¿ÍÀÇ °øµ¿ ¿¬±¸µµ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù. ´ºÀ×±Û·£µå ¹ÙÀÌ¿À·¦½º´Â ¶ÇÇÑ ´Ù¾çÇÑ ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷ÀÇ ±¸»ö°ú À¯ÀüÀÚ ¿¬±¸¸¦ ÃßÁøÇϱâ À§ÇÑ ¼¼°èÀû ¿¬±¸±â°ü°úÀÇ Á¦ÈÞ·Î ¾Ë·ÁÁø Áß¿äÇÑ ±â¾÷ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ±â¾÷µéÀº Àμö, Á¦ÈÞ, Àü·«Àû ÆÄÆ®³Ê½ÊÀ» Ȱ¿ëÇÏ¿© ±â¼ú Çõ½Å°ú ½ÃÀå¿¡¼­ÀÇ Á¸Àç°¨À» È®´ëÇϰí ÀÖÀ¸¸ç, ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷ ½ÃÀå ÀüüÀÇ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷ ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷ÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷ »ê¾÷ÀÇ Á¶»ç

Á¦5Àå ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷ ½ÃÀå : COVID-19ÀÇ ¿µÇ⠺м®

Á¦6Àå ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷ ½ÃÀå »óȲ

Á¦7Àå ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷ ½ÃÀå : ¼¼Æ÷ À¯Çüº°

Á¦8Àå ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷ ½ÃÀå : ÄÄÇÇÅϽà À¯Çüº°

Á¦9Àå ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷ ½ÃÀå : ¿ëµµº°

Á¦10Àå ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

Á¦11Àå ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷ ½ÃÀå : Áö¿ªº°

Á¦12Àå ÁÖ¿ä º¥´õ ºÐ¼® - ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷ ¾÷°è

Á¦13Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á

BJH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

Electrocompetent Cells Market size was valued at USD 2,177.98 Million in 2023, expanding at a CAGR of 10.6% from 2024 to 2032.

The Electrocompetent Cells Market focuses on cells capable of taking up foreign DNA through electrotransformation, essential for genetic engineering and biotechnology applications. Growth in this market is spurred by the rising demand for advanced research tools and biopharmaceutical production, with applications ranging from gene therapy to synthetic biology. For instance, the increasing prevalence of genetic disorders has led to a surge in gene editing research, pushing the demand for high-quality electrocompetent cells. However, challenges such as the high cost of cell preparation and the complexity of the electrotransformation process can impede market growth. Opportunities lie in the development of more cost-effective and efficient electrocompetent cells, driven by advancements in biotechnology and increased research funding. Additionally, the expansion of genomic research and the growing focus on personalized medicine further boost the need for these cells, exemplified by recent collaborations between biotech firms and research institutions aimed at enhancing genetic modification techniques.

Electrocompetent Cells Market- Market Dynamics

Increasing Prevalence of Genetic Disorders Boosts Demand for Electrocompetent Cells

The rising prevalence of genetic disorders is significantly increasing the demand for electrocompetent cells, essential for gene cloning and genetic engineering. For instance, the National Institutes of Health (NIH) reported a 30% increase in research projects involving genetic disorders over the past five years. The World Health Organization (WHO) highlighted that genetic disorders affect approximately 1 in 200 live births, driving the need for advanced research tools. Companies like Bio-Rad Laboratories and Thermo Fisher Scientific have expanded their portfolios to include advanced electrocompetent cells, responding to the growing focus on genetic research and therapy. This surge in demand underscores the critical role of electrocompetent cells in accelerating advancements in genetic research and personalized medicine.

Electrocompetent Cells Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 10.6% over the forecast period (2024-2032)

Based on Cell Type segmentation, Bacterial Cells were predicted to show maximum market share in the year 2023

Based on Competency Type segmentation, Electrocompetent Cells were the leading type in 2023

Based on Application segmentation, Protein Expression was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Electrocompetent Cells Market- Segmentation Analysis:

The Global Electrocompetent Cells Market is segmented based on Cell Type, Competency Type, Application, End-User, and Region.

The market is divided into four categories based on Cell Type: Bacterial Cells, Yeast Cells, Plant Cells, and Mammalian Cells. Bacterial cells lead in demand due to their widespread use in genetic research, followed by yeast cells, which are crucial for functional studies. Mammalian cells are important for advanced applications, while plant cells are less prevalent.

The market is divided into two categories based on Competency Type: Chemically Competent Cells and Electrocompetent Cells. Electrocompetent cells are prioritized due to their efficiency in transformation processes, while chemically competent cells are used in specific applications. Electrocompetent cells hold a higher market share due to their versatility and effectiveness in gene manipulation.

Electrocompetent Cells Market- Geographical Insights

North America leads due to its robust biotechnology sector and significant research investments. The U.S., with institutions like the National Institutes of Health, supports extensive research in genetic engineering, contributing to the region's dominance. Europe follows, driven by its strong pharmaceutical and biotech industries. The European Union's Horizon Europe program funds numerous projects in genetic research and cell technology, boosting market growth. Asia-Pacific, notably China and India, is emerging rapidly due to increasing research activities and investments in biotechnology. China's national policies favor advancements in genetic research and biotechnology, with several collaborations between local universities and biotech firms enhancing market presence. In Latin America, Brazil is making strides with increasing research facilities and collaborations with international biotech companies. Each region is contributing to the global market with varied strengths, driven by regional research initiatives and supportive policies.

Electrocompetent Cells Market- Competitive Landscape:

Invitrogen Corporation, a prominent player, has strengthened its position through strategic collaborations, including a partnership with the University of California for advancing genetic research applications. Bio-Rad Laboratories, another leading company, recently expanded its product portfolio by acquiring the cell biology division of a major biotech firm, enhancing its offerings in electrocompetent cells. Agilent Technologies has been active in forming research partnerships to innovate in genetic engineering, including collaborations with several pharmaceutical companies to develop new applications. New England Biolabs is also a significant player, known for its extensive range of electrocompetent cells and its partnership with global research institutions to advance genetic research. These companies are leveraging acquisitions, collaborations, and strategic partnerships to innovate and expand their market presence, contributing to the overall growth of the Electrocompetent Cells Market.

Recent Developments:

In April 2022, Thermo Fisher Scientific introduced the Gibco CTS Xenon Electroporation System, designed for large-scale cell therapy development. This system enhances gene modification efficiency and allows a seamless transition from clinical to commercial manufacturing, achieving high cell viability and transfection rates.

In January 2020, SGI-DNA launched Vmax(TM) X2 Competent Cells, derived from the marine bacterium Vibrio natriegens. These cells grow twice as fast as E. coli, yielding two to four times more soluble protein, significantly enhancing protein expression efficiency and flexibility for researchers.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ELECTROCOMPETENT CELLS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

GLOBAL ELECTROCOMPETENT CELLS MARKET, BY CELL TYPE- MARKET ANALYSIS, 2019 - 2032

GLOBAL ELECTROCOMPETENT CELLS MARKET, BY COMPETENCY TYPE- MARKET ANALYSIS, 2019 - 2032

GLOBAL ELECTROCOMPETENT CELLS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

GLOBAL ELECTROCOMPETENT CELLS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

GLOBAL ELECTROCOMPETENT CELLS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

Table of Contents

1. Electrocompetent Cells Market Overview

2. Executive Summary

3. Electrocompetent Cells Key Market Trends

4. Electrocompetent Cells Industry Study

5. Electrocompetent Cells Market: COVID-19 Impact Analysis

6. Electrocompetent Cells Market Landscape

7. Electrocompetent Cells Market - By Cell Type

8. Electrocompetent Cells Market - By Competency Type

9. Electrocompetent Cells Market - By Application

10. Electrocompetent Cells Market - By End-User

11. Electrocompetent Cells Market- By Geography

12. Key Vendor Analysis- Electrocompetent Cells Industry

13. 360 Degree Analyst View

14. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â